Cart
Article
Scaffold Hopping with Molecular Field Points: Identification of a Cholecystokinin-2 (CCK2) Receptor Pharmacophore and Its Use in the Design of a Prototypical Series of Pyrrole- and Imidazole-Based CCK2 Antagonists
Full Text HTML
Hi-Res PDFPurchase the full-text
- PDF/HTML,
figures/images,
references and tables,
(where available)
Section:Abstract
A new molecular modeling approach has been used to derive a pharmacophore of the potent and selective cholecystokinin-2 (CCK2) receptor antagonist 5 (JB93182), based on features shared with two related series. The technique uses “field points” as simple and effective descriptions of the electrostatic and van der Waals maxima and minima surrounding a molecule equipped with XED (extended electron distribution) charges. Problems associated with the high levels of biliary elimination of 5 in vivo required us to design a compound with significantly lower molecular weight without sacrificing its nanomolar levels of in vitro activity. Two new series of compounds were designed to mimic the arrangement of field points present in the pharmacophore rather than its structural elements. In a formal sense, two of the three amides in 5 were replaced with either a simple pyrrole or imidazole, while some features thought to be essential for the high levels of in vitro activity of the parent compounds were retained and others deleted. These compounds maintained activity and selectivity for this receptor over CCK1. In addition, the reduction in molecular weight coupled with lower polarities greatly reduced levels of biliary elimination associated with 5. This makes them good lead compounds for development of drug candidates whose structures are not obviously related to those of the parents and represents the first example of scaffold hopping using molecular field points.
Citing Articles
Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
This article has been cited by 13 ACS Journal articles (5 most recent appear below).
SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening
Xiaofeng Liu, Hualiang Jiang, and Honglin LiJournal of Chemical Information and Modeling2011 51 (9), 2372-2385SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening
Xiaofeng Liu, Hualiang Jiang, and Honglin LiJournal of Chemical Information and Modeling2011 51 (9), 2372-2385We developed a novel approach called SHAFTS (SHApe-FeaTure Similarity) for 3D molecular similarity calculation and ligand-based virtual screening. SHAFTS adopts a hybrid similarity metric combined with molecular shape and colored (labeled) chemistry ...
De Novo Molecular Modeling and Biophysical Characterization of Manduca sexta Eclosion Hormone
J. Joe Hull, Kathrin S. Copley, Kathleen M. Schegg, David R. Quilici, David A. Schooley and William H. WelchBiochemistry2009 48 (38), 9047-9060De Novo Molecular Modeling and Biophysical Characterization of Manduca sexta Eclosion Hormone
J. Joe Hull, Kathrin S. Copley, Kathleen M. Schegg, David R. Quilici, David A. Schooley and William H. WelchBiochemistry2009 48 (38), 9047-9060Eclosion hormone (EH) is an integral component in the cascade regulating the behaviors culminating in emergence of an insect from its old exoskeleton. Little is known regarding the EH solution structure; consequently, we utilized a computational approach ...
LigMatch: A Multiple Structure-Based Ligand Matching Method for 3D Virtual Screening
Sarah L. Kinnings and Richard M. JacksonJournal of Chemical Information and Modeling2009 49 (9), 2056-2066LigMatch: A Multiple Structure-Based Ligand Matching Method for 3D Virtual Screening
Sarah L. Kinnings and Richard M. JacksonJournal of Chemical Information and Modeling2009 49 (9), 2056-2066We have developed a new virtual screening (VS) method called LigMatch and evaluated its performance on 13 protein targets using a filtered and clustered version of the directory of useful decoys (DUD). The method uses 3D structural comparison to a ...
Novel Lead Structures for p38 MAP Kinase via FieldScreen Virtual Screening
Timothy J. Cheeseright, Melanie Holm, Frank Lehmann, Sabine Luik, Marcia Göttert, James L. Melville and Stefan LauferJournal of Medicinal Chemistry2009 52 (14), 4200-4209Novel Lead Structures for p38 MAP Kinase via FieldScreen Virtual Screening
Timothy J. Cheeseright, Melanie Holm, Frank Lehmann, Sabine Luik, Marcia Göttert, James L. Melville and Stefan LauferJournal of Medicinal Chemistry2009 52 (14), 4200-4209p38 MAP kinase has received considerable interest in the pharmaceutical industry and remains a valid and interesting target for the treatment of inflammation. To discover novel p38 inhibitors, we applied the ligand-based virtual screening technique, ...
FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set
Timothy J. Cheeseright, Mark D. Mackey, James L. Melville and Jeremy G. VinterJournal of Chemical Information and Modeling2008 48 (11), 2108-2117FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set
Timothy J. Cheeseright, Mark D. Mackey, James L. Melville and Jeremy G. VinterJournal of Chemical Information and Modeling2008 48 (11), 2108-2117FieldScreen, a ligand-based Virtual Screening (VS) method, is described. Its use of 3D molecular fields makes it particularly suitable for scaffold hopping, and we have rigorously validated it for this purpose using a clustered version of the Directory of ...
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue November 03, 2005
- Received November 18, 2004
ACS
Network
Facebook
Tweet This
CiteULike
Newsvine
Digg This
Delicious
